Considering that activation of PXR signaling may induce hypercholesterolemia and cirrhosis, the combination of this finding also suggests that PXR activation should be considered in patients on long-term PXR agonistic antiretroviral drugs (21). This evidence concerns the gene NR1I2 and familial hypercholesterolemia.